Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
Clinical trial NCT00006033 · COMPLETED
Trial details
- NCT number
- NCT00006033
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.